Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

Suzuken Co., Ltd. (SZUKF)

Compare
30.30
0.00
(0.00%)
At close: April 4 at 4:00:00 PM EDT
Loading Chart for SZUKF
  • Previous Close 0.00
  • Open 30.30
  • Bid 30.44 x --
  • Ask 35.40 x --
  • Day's Range 30.30 - 30.30
  • 52 Week Range 24.06 - 30.30
  • Volume 100
  • Avg. Volume 0
  • Market Cap (intraday) 2.72B
  • Beta (5Y Monthly) 0.17
  • PE Ratio (TTM) 11.43
  • EPS (TTM) 2.65
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Mar 28, 2025
  • 1y Target Est --

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy, and Healthcare-Related Services. The Pharmaceutical Distribution Business segment is involved in the purchase and sale of ethical drugs, pharmaceuticals, diagnostic reagents, and medical equipment and supplies to medical institutions and insurance pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals, and diagnostic reagents focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment is involved in the medication instruction and drug management for in-home patients, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment delivers drugs; provides nursing care services; manufactures, sells, and leases nursing care and medical equipment, such as electrocardiographs, blood pressure monitors, and stethoscopes under Kenz brand name; distributes orphan drugs; develops and operates a product control system for medical materials; sells food products and fixtures and fittings; and develops, manages, and maintains healthcare platforms. This segment also engages in publication and PR activities in the field of medical care and health; and insurance agency business, as well as provides remote image diagnostic support services. In addition, it engages in pharmaceutical logistics business. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.

www.suzuken.co.jp

13,086

Full Time Employees

March 31

Fiscal Year Ends

Recent News: SZUKF

View More

Performance Overview: SZUKF

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

SZUKF
253.81%
Nikkei 225 (^N225)
15.33%

1-Year Return

SZUKF
197.92%
Nikkei 225 (^N225)
15.07%

3-Year Return

SZUKF
2,580.31%
Nikkei 225 (^N225)
21.79%

5-Year Return

SZUKF
119,975.68%
Nikkei 225 (^N225)
89.56%

Compare To: SZUKF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SZUKF

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    2.37B

  • Enterprise Value

    980.17M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.42%

  • Return on Assets (ttm)

    1.83%

  • Return on Equity (ttm)

    8.29%

  • Revenue (ttm)

    2.41T

  • Net Income Avi to Common (ttm)

    34.19B

  • Diluted EPS (ttm)

    2.65

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    205.53B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: SZUKF

View More

Company Insights: SZUKF

Research Reports: SZUKF

View More

People Also Watch